Form 4 for BCPC BALCHEM CORP
Accepted 2024-08-01 00:00:00 ET · period of report 2024-07-30 · accession 0001140361-24-035394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-01 | 2024-07-30 | BCPC | Backus William A. | VP, CAO | S - Sale+OE | $179.35 | -3,900 | 5,318 | -42% | -$699.5K |
| D | 2024-08-01 | 2024-07-30 | BCPC | Backus William A. | VP, CAO | M - OptEx | $84.09 | +3,900 | 8,888 | +78% | +$328.0K |
| DI | 2024-08-01 | 2024-07-30 | BCPC | Backus William A. | VP, CAO | S - Sale+OE | $177.10 | -904 | 132 | -87% | -$160.1K |
| D | 2024-08-01 | 2024-07-30 | BCPC | Backus William A. | VP, CAO | M - OptEx | $0.00 | -3,900 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-30 | S | D | 330 | $180.47 | 4,988 | D | — | — | (F3) This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 2 | Common | Common Stock | 2024-07-30 | S | D | 3,570 | $179.25 | 5,318 | D | — | — | (F2) This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 3 | Common | Common Stock | 2024-07-30 | M | A | 3,900 | $84.09 | 8,888 | D 401(k) Plan | — | — | (F1) Exercise of fully vested non-qualified stock options. |
| 4 | Common | Common Stock | 2024-07-30 | S | D | 904 | $177.10 | 132 | I | — | — | (F4) Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan. (F5) Reflects shares previously acquired under the Balchem Corporation 401(k) plan. |
| 5 | Derivative | Stock Options (right to buy) | 2024-07-30 | M | D | 3,900 | $0.00 | 0 | D | $84.09 · — to 2029-02-13 | 3,900 Common Stock | (F6) Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable. |